Can Follistatin Levels Help Distinguish Between Metabolically Healthy and Unhealthy Obese Individuals
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- relation between follistatin and metabolically healthy and unhealthy obesity
研究概览
简要总结
There is no clear boundary on which obese individuals should be considered metabolically healthy and which should be considered metabolically unhealthy. It is also not very clear whether the individuals who are considered metabolically healthy will remain healthy in the future. The objective of this study was to assess potential disparities in serum follistatin levels between these two distinct groups. Furthermore, the study sought to investigate whether this disparity could serve as a reliable indicator for distinguishing between metabolically healthy and unhealthy obese individuals.
详细描述
Individuals with similar body mass indexes may have different metabolic health and cardiovascular risks. Research shows that some individuals with comparable body mass index (BMI) are metabolically healthy and have a lower risk of cardiovascular issues, while others are metabolically unhealthy and have a higher risk. Studies indicate that the lifestyles of metabolically healthy and unhealthy obese individuals, such as diet, physical activity, and sleep patterns, do not differ significantly, even though the individuals have similar levels of total or subcutaneous adiposity. However, it has been shown that metabolically healthy obese individuals tend to have lower levels of visceral adiposity compared to unhealthy ones.
Patients with BMI≥30, who applied to the internal medicine clinic, were included in the study. Among these patients, those without criteria of metabolic syndrome other than an increase in waist circumference (blood pressure ≥130/85 mmHg, fasting blood sugar ≥100 mg/dl, triglycerides ≥150 mg/dl, HDL-cholesterol <40 mg/dl in men and <50 mg/dl in women) and without prediabetes were defined as metabolically healthy obese individuals. Those with at least 1 metabolic syndrome criterion other than an increase in waist circumference were classified as metabolically unhealthy obese individuals. The participants' fasting blood sugar levels, HbA1c levels, insulin levels, lipid panel results, liver enzymes levels,urea levels, creatinine levels, whole blood count, and thyroid hormones were examined. Anthropometric measurements including height,weight and waist circumference were also taken for each individual.
Participants were then invited back to repeat follistatin levels.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Having given consent to the study
- •Being over 18 years of age
- •Being under 60 years of age
- •Body mass index >=30 kg/m2
排除标准
- •Antidiabetic medication usage
- •obesity surgery
- •Antihypertensive medication usage
- •Those receiving lipid-lowering therapy
- •Pregnant women
- •Those with hypo/hyperthyroidism
- •Steroid use
- •Benign/malignant tumors
- •Advanced liver disease
- •Secondary causes of obesity
结局指标
主要结局
relation between follistatin and metabolically healthy and unhealthy obesity
时间窗: baseline
This study aims to examine the correlation between follistatin levels and both metabolically healthy and unhealthy individuals with obesity
threshold for follistatin in metabolic evaluation of obesity
时间窗: baseline
The establishment of a threshold value for follistatin levels in assessing metabolic health in obese individuals.
次要结局
未报告次要终点
研究者
Ayse N Erbakan
Principal investigator
Goztepe Prof Dr Suleyman Yalcın City Hospital
